health
New Blood Biomarkers Show Promise for Early Alzheimer’s Diagnosis
Research into P-tau217 and genetic markers aims to enhance early detection of Alzheimer’s disease and personalised treatment approaches.
Recent advancements in Alzheimer’s diagnosis may soon allow for earlier identification of the disease through blood testing. Particularly, a protein known as phosphorylated tau 217, or P-tau217, is emerging as a promising blood-based biomarker. This ... [3667 chars]
Read Full ArticleShare this story
Up next
Related Stories
What happens when middle-aged adults take creatine for 12 weeks? New study finds muscle gains even without structured exercise
The Economic Times
Study Links Oral Menopausal Hormone Therapy to Thrombotic Risk
Drug Topics
Smartphone retinal imaging could expand global eye care screening
News-Medical
Why does endometriosis only cause major pain for some?
Futurity
Are You Always Up Past Midnight? Study Reveals How Sleeping Late May Affect Your Body’s Cancer Defences
News18